Company Filing History:
Years Active: 1985-1986
Title: Andras Rado: Innovator in Pharmaceutical Chemistry
Introduction
Andras Rado is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of histamine H-2 receptor antagonists. With a total of 2 patents, Rado's work has had a meaningful impact on medical science.
Latest Patents
Rado's latest patents include innovative formulations of cimetidine, a well-known histamine H-2 receptor antagonist. The first patent describes a new monohydrate form of cimetidine, specifically N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N'-cyanoguanidine H. This invention outlines a process for preparing the monohydrate by pouring a hot, homogeneous aqueous solution onto ice, leading to the separation of the desired compound. The second patent introduces a new crystal modification of cimetidine, referred to as N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N'-cyanoguanidine Z. This modification also includes a detailed process for its preparation.
Career Highlights
Andras Rado is currently associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on innovative drug formulations and contribute to advancements in therapeutic options for patients.
Collaborations
Rado has collaborated with esteemed colleagues such as Kalman Harsanyi and Gyorgy Domany. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.
Conclusion
Andras Rado's contributions to pharmaceutical chemistry, particularly through his patents on cimetidine, highlight his role as an innovator in the field. His work continues to influence the development of effective medical treatments.